Clinical Trial Update: A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2a randomized trial evaluating the efficacy and safety of TFC-003 in primary open-angle glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TFC-003

Snippet

Sponsor: Kukje Pharma | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: UNKNOWN